Cancer stem cells possess the qualities of self-renewal, tumorigenesis and the ability to recapitulate a heterogeneous tumor. Our group was the first to isolate head and neck squamous cell carcinoma (UNSCC) stem cells using the cell surface marker CD44. CD44 is a trans-membrane glycoprotein with a multitude of key-functions that regulate cancer cell proliferation and metastasis. The variety of CD44 functions is due to tissue-specific patterns of glycosylation of the extracellular portion, and to the multiple protein isoforms (CD44 variants, CD44v) generated by alternative splicing. This study investigates the expression pattern of CD44 variants in UNSCe. Ten cell lines from the most common UNSCC locations and representative of various clinical outcomes were assayed by quantitative realtime PCR, flow cytometry and immunofluorescence comparatively with normal oral keratinocytes. The CD44 v4 and v6 were exclusively abundant in UNSCC while the isoform vt,2 was expressed in normal oral keratinocytes. Of interest, the highest level of CD44v6 expression was detected in advanced metastatic UNSCC, suggesting a link between CD44v6 expression and UNSCC metastasis, while the highest CD44v4 was detected in a stage IV UNSCC refractory to chemotherapy which developed recurrence. Oral-derived UNSCC expressed the highest CD44v4 and v6, and levels corresponded with staging, showing also an increasing tendency with recurrence and metastasis. CD44v were detected predominantly in smaller cells (a characteristic that has been associated with stem cell properties) or cells with mesenchymal morphology (a characteristic that has been associated with the migratory and invasive potential of epithelial tumor cells), suggesting that CD44v differential expression in UNSCC may be representative of the morphological changes inherent during tumor progression towards a more aggressive potential, and thus contributing to the individual tumor biology. The mechanism of CD44 variant involvement in UNSCC progression and metastasis is under investigation.
and invasiveness (I, 2) . HNSCC is associated with poor clinical outcome and mortality rates among the highest of all carcinomas (2) . As epithelial tumors, HNSCCs contain a heterogeneous population of cancer cells. The cancer stem cell (CSC) hypothesis has attributed this cellular heterogeneity of epithelial tumors to the stem-like properties of a subpopulation of cells within the tumor; this subpopulation through differentiation and uncontrollable division can drive tumorigenesis, giving rise to the bulk of the tumor (I). Our group has identified CD44 as a cell-surface marker that can enrich a population with stem like properties (I). Cancer cells with high CD44 reactivity, CD44 high , typically comprise <10% of the cells in a HNSCC tumor. CD44 high cells but not CD44 10w cancer cells give rise to new tumors in vivo and co-stain with the basal cell marker Cytokeratin 5/14. The tumors that arise from sorted CD44 high cells reproduce the original tumor heterogeneity and can be serially passaged, thus demonstrating both an ability to self-renew and an ability to differentiate. Furthermore, the tumorigenic CD44 high cells differentially express the BM!! gene, a marker of self-renewal and tumorigenesis (I). Large numbers of CD44 high cells are found within primary tumors and are required to grow tumors in the mouse model (I, [3] [4] [5] , suggesting that CD44 variants and its differential expression may provide a better marker for tumor stem cells.
CD44, the major receptor of hyalorounan, is a cell-surface glycoprotein involved in cell-cell interactions, cell migration and adhesion, with multiple isoforms (splice variants) known to be associated with cell transformation and tumor dissemination (5) (6) (7) (8) (9) (10) . CD44 mediates cellular adhesion, signal transduction and the linking of extracellular matrix with the cytoskeleton. The major source of post-translational modification of CD44, covalent binding of chondroitin sulfate side chains, depends on the pattern of exon splicing (11). These splice isoforms, or CD44 variants display varying ligand binding properties and have been implicated in tumorigenesis and metastatic progression for a variety of tumors (5, (12) (13) (14) .
CD44 protein is also expressed in soluble form (soICD44), which is detectable in normal circulation (15) (16) (17) (18) (19) (20) . Circulating levels of solCD44 correlate with metastasis in some tumors (5, 17) . It has recently been shown that solCD44 levels in the saliva of HNSCC patients may have potential as a disease marker (21) . In this study, we investigate the differential expression profile of the CD44 isoforms in HNSCC, to assess whether a CD44 variant may be a better marker than standard CD44 for HNSCC stem cells and to examine the plausibility of its use as a possible diagnostic and prognostic tool.
We tested the levels of the standard CD44 and of various CD44 variants in a panel of HNSCC cell established by our group (22, 23) 23 ) by flow cytometry. We compared RNA expression levels ofvariant isoforms containing exons 6,7 (VI,2) or 10 (V4) or 12 (V6) in these cells with those of Normal Oral Keratinocytes (NOK) by quantitative real time RT-PCR and verified the presence of the v4 and v6 isoforms with variant specific antibodies by immunohistochemistry and Fluorescence Activated Cell sorting (FACS). Development of these techniques is necessary to study the biological mechanism ofCD44 contribution to tumorigenesis.
This work reveals that while normal oral keratinocytes express the CD44vl,2 variant form of CD44, CD44v4 and CD44v6 are associated with HNSCC tumorigenesis. Of interest, the highest expression of CD44v6 was detected in advanced metastatic HNSCC, suggesting a link between CD44v6 expression and HNSCC metastasis, while the highest CD44v4 was detected in a stage IV HNSCC refractory to chemotherapy which developed recurrence. Flow cytometry analysis indicates that oral-derived HNSCC expressed highest CD44v4 and v6 levels relative to staging, while also showing an increasing tendency with recurrence and metastasis. While these principles are true for oral HNSCC, the expression of another variant may account for the high expression of CD44 observed in non-oral HNSCC with the standard antibody observed by FACS.
We show by immunofluorescence that variant forms of CD44 are predominantly expressed in cells with a distinct mesenchymal phenotype among cells cultured from a highly aggressive oral cancer, while an antibody recognizing all CD44 is delineating the plasma membrane in CD44 low cells and the philopodia required for normal cell to cell contact.
In a cell culture of highly tumorigenic oral cancer, UMSCC-14A, the overall cell phenotype was more mesenchymal and the antibodies against the CD44v4 and CD44v6 recognized highly polarized, dendriticlike cells. Additionally, we observed the presence of CD44 variant forms in smaller cells, a characteristic that has been associated with stem cell properties (14) .
Taken together, our study points to the heterogeneity of the CD44+ populations in HNSCC, which may be indicative of a more aggressive potential. This highlights the need for understanding the biological significance of each isoform and suggests that typing tumor biopsies for their CD44 profile may provide important information on their clinical prognostic.
MATERIALS AND METHODS

Cell lines and cell culture
AIl ceIl lines used in this study were established at the University of Michigan (UM) under a protocol approved by the IRB Office in accordance with the University's regulations (22) . CoIlection of cancer specimens from subjects at the UM Hospital, Ann Arbor was approved through the appropriate UM review boards with written informed patient consent. The ceIl lines [University of Michigan Squamous CeIl Carcinomas (UMSCC)] used in this study were established by our group (22) . Table I summarizes their origin, staging, and treatment subjected to before derivation. AIl carcinoma ceIl lines were cultured in Dulbecco's Modified Eagle Medium (DMEM, Invitrogen, Carlsbad, CA, USA), I% nonessential amino acids, 100X (Invitrogen), and I% Penicillin-Streptomycin, 100X (Invitrogen). The ceIl lines tested negative in periodic monitoring for mycoplasma. The ceIl lines were genotyped to rule out cross-contamination and to confirm their identity, and their morphology was regularly examined. Human Normal Oral Keratinocytes (NOK, ScienCeIl Research Laboratories, Carlsbad, CA, USA) were used as controls and were grown in basal keratinocyte growth media (KGM) supplemented with hydrocortisone, insulin (bovine), human epithelial growth factor and bovine pituitary extract, in accordance with the manufacturer's instructions (Lonza, Walkerswille, MD, USA).
Real Time RT-PCR (qRT-PCR)
RNA was extracted from the HNSCC ceIl lines using the PCR RNAqueus kit (Ambion, Austin, TX, USA) in accord with the manufacturer's instructions. Superscript III (InVitrogen, Carlsbad, CA, USA) generated cDNAs were verified for CD44 expression (Platinum PCR, InVitrogen); beta-actin was used as internal standards. qRT-PCR was performed on a 7900H ABI machine using Roche Fast Start" SYBR Green mix (with ROX) according to the manufacturer's instructions. CD44 and its isoform values for carcinoma ceIl lines were normalized against corresponding values of NOK ceIls. Values were averaged and standard deviations were included in the reported means.
Fluorescence Activated Cell Sorting (FACS)
Sorting experiments were performed at the Flow Cytometry Core Facility at the University of Michigan on a BD Biosciences FACS Vantage CeIl Sorter. The single-ceIl suspension were washed, counted and then resuspended to a concentration of 10 6 ceIls per I miIliliter. Washes and incubation with antibodies were carried out in Hank's Balanced Salt Solution (HBSS) with 2% heat inactivated calf serum (HICS). Numbers of total viable ceIls were assessed by 4,6-diamidino-2-phenylindole (DAPI, at 0.5 ml per 10 6 ceIls; BD Pharmingen) exclusion. The foIlowing antibodies were used: anti-CD44 (aIlophycocyanin APC-conjugated mouse antihuman, clone G44-26; BD) and anti-human CD44v4 and v6 antibodies (R&D Systems, Minneapolis, MN) which were detected by APC633 and Alexa Fluor488 anti-mouse antibodies (InVitrogen). AIl antibodies were used at a final concentration of 2 microgram/milliliter. Gates were set as foIlows: samples incubated without antibody were used to account for autofluorescence; samples incubated with the isotype control antibodies (aIlophycocyanin APC-conjugated mouse IgG2b K, clone 27-35 and FITC mouse IgM, BD) were used to control for nonspecific binding. Viable ceIls assessed by DAPI exclusion were gated for forward and orthogonal light scatter with filters appropriate for the fluorescent antibody tag. The 10-15% of ceIls with the highest CD44 expression were coIlected as CD44 hig \ while the 10-15% with the lowest or no expression as CD44 10w ceIls (3).
Immunofluorescence
Cells were grown in slide chambers (BD Pharmigen) then fixed with 4% formalin for 30 min on ice. Image FX™ enhancer (InVitrogen) was used prior to blocking with normal rabbit serum (5mg/ml) and BSA (2% by weight) in PBS. Antibodies were used as above, incubated in blocking solution, washed in PBS. Images were obtained on a Nikon scope equipped with an Olympus camera and processed on Olympus DSP Image Manager.
RESULTS
CD44+ levels in UMSCC eel/lines
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Fig. 1. Relative levels ofCD44 cells (recognized by pan CD44 antibody). A) Relative CD44 percentages in UMSCC cell lines recognized by the pan-CD44 antibody and processed by FACS as described in Methods. The population includes cells with any level ofCD44 expression. A shows a graph of percentages ofthe gated live cell population that exhibited CD44 reactivity with a pan-CD44 antibody. with the thresholdfor expression defined by staining with an isotype control. Live cells were gated for DAPI exclusion and fluorescence in the F1TC-range (Ml gate) as shown in B. Maximum standard deviation between experimental repeats was 8% of the reported value and error bars in
... B. CD44v4 expr ession in HNSCCCcell lines (norma lized to NOK) . EC Table I . eel/lines and their characteristics.
. CD44 isof orms immunofluorescence in HNSCC derived f rom a very aggressive stage IV metastatic oral carcinoma, UMSCC-I03 . Upper panel: Immunofluorescence microscopy using pr imary antibodies against isofonns containing exons 1.2 (A -C) and variants v6 (D-F) and v4 (G-l) showed diff erential pattern of exp ressionfor the CD44_1,2 and the variants. While the f ormer delineates the plasma membrane and cell-to-cell boundaries, the variants seem to mark cells with a more mesenchymal morphology. All forms of CD44 are seen in higher magnification to participate in philopodia. Variants, particularly V6. are also seen in fo rmations similar to intracellular and extracellular vesicles. Dotted arrows denote CD44 hiKh , arrow heads denote CD44 hiKh and small size cells, stars show vesicles recognized by antibody, angled arrow po ints to philopodia and regular arrow to pola rized phenotype. Lower pan el: Quantitative Real Time R T-PCR of UMSCC-103 tumor cells separated by FACS as CD44 hiKh versus CD44 1ow • Following our standardprotocol (3) the 10-15% of cells with the highest expression (harboring the cancer stem cell population) are isolated and collected by FACS as CD44 high and the 10-15% with the lowest or no exp ression are usually collected as CD44 10w cells. For each CD44 isoform tested values shown represent relative levels ofexpression ofCD44 high compared to values ofCD44 low
The eel/lines used in this study and their complete information: the degree ofdifferentiation as shown by cytology (Gradel Differentiation), the stage of the cancer at the time ofcell line derivation (Stage). the head and neck site ofthe biopsy (Specimen Site), whether the biopsy was ofprimary, recurrent or metastatic lesion (Type oflesion), what the primary site ofoccurrence had been (Primary Site) and the treatment received by the patient prior to eel/line derivation (Previous Treatment).
IIA, an advanced stage (IV) primary carcinoma resistant to the conventional treatment regimens, had the highest expression of CD44v4 while UMSCC-lOB, a high stage metastatic carcinoma, expressed the highest CD44v6. UMSCC-14A&B, early stage (I) oral carcinomas cell lines, had the most moderate increases in all isoforms with -14A expressing 40fold more CD44v4 than NOK. It is conceivable that in this cell line most CD44 is in the standard form or of another isoform that we did not test for (e.g. V7). However, all the CD44 variants tested, as well as the overall relative levels ofCD44+, were higher in -14A than in its corresponding recurrence -14B. Overall, real time quantitative RT-PCR was successful in detecting variant forms of CD44 that were not present in normal oral keratinocytes. Our data also indicates that in both oral-and non-oralderived HNSCC, the recurrence-forming tumors express both higher CD44v4 and v6 in their primary tumor than in their corresponding recurrences. The levels of expression increased with the tumor stage and were highest in the non-oral-derived HNSCC cell lines. In the metastatic tumors , those variants were higher than in their primary HNSCC counterparts.
Relative CD44+" ecells recognized by FA CSanalysis
Next, we proceeded to test how well the q RT-PCR data were reflected in FACS analysis using antibodies against all CD44 (pan-CD44) or specifically against its variants. We found CD44v4 levels detectable by FACS in the oral-derived UMSCC-14A and -103 lines but not in the larynx-originated UMSCC-II B cells, while CD44v6 was detectable in all of them (Fig. 3) . Levels of variant forms in long-term established cell lines were significantly lower than in freshly established ones such as UMSCC-I03 cells which were recently isolated from a very aggressive metastatic HNSCC primary oral carcinoma (3).
Expression of CD44 as detected by the pan-CD44 antibody is 19 times higher than that detected by the CD44v6 antibody in UMSCC-llB cells (15.2 vs 0.8), 44 times higher (48.1 vs 1.1) in UMSCC-l4A cell line and 1.7 times higher in UMSCC-l03 cells (32.1 vs 18.3). The CD44v4 isoform was not detectable by FACS in UMSCC-ll B cells, and the CD44vl,2 isoform was expressed 29 times less than CD44vl,2 isoform in UMSCC-14A cells and only 2.7 times less than the CD44v 1,2 in UMSCC-l03 cells. Further analysis will require investigation of the effects of tissue culture on CD44 expression in UMSCC cells over time comparatively with its differences in the corresponding primary tumor fresh biopsies.
Flow cytometry analysis indicated that oralderived HNSCC expressed highest CD44v4 and CD44v6 and levels corresponded with staging, showing also an increasing tendency with recurrence and metastasis ( Fig. 3) .
Using our standard protocol, the 10-15% of cells with the highest expression (harboring the cancer stem cell population) were isolated and collected by FACS as CD44 high and the 10-15% with the lowest or no expression were usually collected as CD44 10w cells, as we previously reported (3) . The levels of CD44 isoforms in CD44 high versus CD44 10w cells from the oral-derived stage IV metastatic (both distant and in the lymph nodes) UMSCC-l03 cell line are illustrated in Fig. 4 . qRT-PCR was run to compare isoform expression in CD44 high versus CD44 10w cells. We found that expression of variants v4 and v6 was enriched in the CD44 high compartment by 4and 2-fold respectively, while the vl,2 isoform was expressed equally in CD44 high versus CD44 10w cells.
CD44+ ve reactivity visualized by immunofluorescence inHNSCC
The immunostaining results indicate that the oralderived HNSCC cell lines exhibited highest CD44 expression as detected by FACS analysis (Figs. 4 and 5) . Immunofluorescent microscopy also showed differential pattern of expression for the pan-CD44 and the variant antibodies ( Fig. 4 D-F and G-I). While the standard form of CD44 delineates the plasma membrane and cell-cell boundaries, the variants seem to mark cells with a more mesenchymal morphology and a smaller size. All forms of CD44, but mostly CD44vl,2, are seen in higher magnification to participate in philopodia. UMSCC-l 03 cells showed CD44vl,2 reactivity at the plasma membrane and delineating the philopodia. The philopodia are only detectable if a Triton-X permeabilization step is omitted during the immunochemistry. CD44 staining in dividing cells labeled the cellular apparatus involved in cell division, and specifically the centers of organization of microtubules at the poles of diving cells (centriole). Reactivity by immunocytochemistry did not pick up any variant forms for this cell line, indicating that both FACS and real time RT-PCR have higher sensitivity. Fluorescent immunocytochemistry seems most valuable in providing an insight for the potential biological functions of CD44 as extrapolated from their pattern of cellular distribution. In the oralderived cell line UMSCC-14A antibodies against the CD44 variant forms gave strong signal for cells with a highly polarized, almost dendritic cell profile and were very rare among the general population of cells consistent with the qRT-PCR data.
DISCUSSION
CD44 is a cell-surface marker that can enrich a population with stem cell-like properties in HNSCCs (1). CD44 high cells, but not CD44 10w cancer cells, give rise to new tumors in vivo that reproduce the original tumor heterogeneity and demonstrate both an ability to self-renew and an ability to differentiate (1, 3, 26, 27) . It has been suggested that tumors that could be successfully xenografted in mice represent a more aggressive phenotype (27) . The importance of CD44 as a tumor-initiating cell marker was also previously shown in in vitro studies rather than studying fresh human tissues (28, 29) . Since a great number (5x 10 3 ) of CD44 high cells is required to give rise to tumors in vivo, we have hypothesized that a more stringent stem cell marker may exist in the CD44 variant isoforms that arise from alternative exon splicing and are usually only seen expressed in tumors (12) (13) (14) . We examined the CD44 expression profile in HNSCC-derived cell lines with the goal to investigate the differential expression of the CD44 isoforms and to examine the plausibility of its use as a possible diagnostic and prognostic tool. Recently, soluble CD44 levels in the saliva of HNCC patients were shown to be a potential disease marker (21) . Our group previously reported that a flow cytometric measurement of CD44+ cells may provide a prognostic test for patients with HNSCC (I, 3, 27) . We examined whether real time RT-PCR would also make a plausible diagnostic tool by comparing data obtained by real-time RT-PCR for CD44 variants with data obtained by FACS analysis and immunocytochemistry. Our data confirmed the real time RT-PCR as a highly sensitive method of CD44 variant detection and showed that CD44 variants v4 and v6 are expressed exclusively in HNSCC but not in normal oral keratinocytes. FACS analysis was also determined to be a highly sensitive method for the detection of the variant forms of CD44 in HNSCC, but a greater amount of starting material is required, making it more difficult to perform as a routine prognostic tool. FACS data verified the over-expression of the CD44 variants and the value of the real time RT-PCR as a test for CD44 variant over-expression in HNSCCs. Immunohistochemistry provided an additional tool for the evaluation of expression of CD44 variants with a valuable insight into the possible biological function of CD44 and its variant forms. Our study indicated CD44vl,2 as native in head and neck epithelia, being expressed in normal oral keratinocytes as well as in the HNSCC cell lines; it delineates the plasma membrane and numerous philopodia protruding from the cell membrane to create cell-to-cell contact. In the UMSCC-Il B cell line the philopodia appear significantly more elongated and seem to mediate cell contact in cells that are not in close proximity. CD44 variants are found in cells that are small, a property that has been associated with stem cell properties of oral keratinocytes (24) or cells that are highly polarized, therefore of a more mesenchymal phenotype that has been associated with a potential for invasion (30) . The presence of CD44 variant forms in smaller cells or cells with mesenchymal morphology is therefore consistent with the hypothesis that CD44 variants might be differentially expressed in HNSCC. A very interesting finding is the high labeling of centriole-like structures as well as very specific "polarized" areas of cells in the process of cell division among the HNSCC cells. This finding suggests an active role for CD44 in cell division, the lack of whose proper control lies at the heart of carcinogenesis. As CD44 mediates cellular adhesion, signal transduction and the linking of extracellular matrix with the cytoskeleton (7-10) in a variety of cells, a rather ubiquitous involvement of CD44 to cancer would be suggested by a central role in cell division and such a biological function merits further exploration. The major source of posttranslational modification of CD44 depends on the pattern of exon splicing (II) and the ligand binding properties of splice isoforms or CD44 variants may vary, but, overall, CD44 isoforms might be involved in polarization of the cell through a communication of the extracellular environment, the cell membrane and the cytoskeleton.
Overall, immunofluorescence staining provided an additional tool for the evaluation of expression of CD44 variants and indicated the presence of CD44 variant forms in smaller cells (a characteristic that has been associated with stem cell properties) or cells with mesenchymal morphology (characteristic of invasive potential of epithelial tumor cells), suggesting that CD44 variants differentially expressed in HNSCC may be representative of morphological changes incurred during tumor progression towards a more aggressive phenotype.
Our results indicate that CD44 variants are more prevalent in CD44 high cells, consistent with the notion that variant forms may be better markers for the cancer stem cells. Previous studies have shown conflicting results regarding the significance of CD44 in head and neck tumors (27) ; the majority of these studies have employed immunohistochemistry as detection method for CD44 and its variants. Our present study has analyzed their expression by a combined approach using three different methods, immunohistochemistry, flow cytometry and realtime PCR comparatively to normal oral epithelia. Therefore, this study provides a new perspective of the CD44 expression profile and significance in HNSCC which supports and completes previous studies (1, 3, 26, 27) .
Taken together, the results of our study pointed to the differential expression of CD44 variants in HNSCC and the potential usefulness of variant detection methods such as real time RT-PCR for the diagnosis ofHNSCC in tumor biopsies. Variationinthe splicing profile of the CD44 variants is great and may be involved in the individual phenotype of HNSCC tumors in a causative or outcome predictive manner. At this time we do not know the exact sequence of transcripts or proteins expressed in HNSCC cells or the possible variations. Our team aims at understanding the biological mechanism of CD44 involvement in HNSCC tumorigenesis. Further analysis will require studies of the genetic profile ofUMSCC HNSCC cell lines and primary tumors. Detailed genetic profiling of CD44 isoforms may be a useful and even necessary step in the future diagnosis ofHNSCC; paired with an understanding of the biological mechanism of action of CD44 and of each of its variants, and the controls on the splicing mechanism that produce such variants, this could conceivably revolutionize the approach to HNSCC diagnosis and treatment. Emerging recent evidence indicates that targeting the individual CD44 variants may hold great promise for therapeutic strategies in cancer patients (31) .
